will add the following:
-reduction in the share count. Therefore when revenues start to flow, faster to get to a 'positive' earnings number (shareholder enhancement tool)
-believe you are saying, 'inflates' the share price to above a minimum the bigger players desire before getting involved. But have to hope this happens at the same time as PR to give those bigger players a reason to pay attention...
ARNA is one of the ones that pulled this type of move off successfully. R/S from $1.40 to $14.00, hyped the hell out of a PH 2 trial result, and managed to push it up to $40+, with the PH 3 not anywhere close to even being developed, let alone run.